Institute of Clinical Medicine

corporate_fareorganization

Country: Taiwan

Institute of Clinical Medicine

- Funding / Projects
  (1)

1 Projects, page 1 of 1

TEIGER (Cancer immunotherapy: rejuvenation of anti-cancer response by immune checkpoint blockade using novel multifunctional nanoparticle to block CTLA-4 and eliminate ICER)
assignment_turned_inProjectFrom 2021Partners:Graduate Institute of Biomedical Sciences, Institute of Inorganic Chemistry, Bldg. A, Rm 106, False, V-Nano, Institute of Clinical Medicine +1 partners
Graduate Institute of Biomedical Sciences,
Institute of Inorganic Chemistry, Bldg. A, Rm 106,
False,
V-Nano,
Institute of Clinical Medicine,
NanoSYS Biologics
Funder: French National Research Agency (ANR) Project Code: ANR-20-ENM3-0009
Funder Contribution: 119,610 EUR
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Institute of Clinical Medicine

Institute of Clinical Medicine

1 Projects, page 1 of 1

TEIGER (Cancer immunotherapy: rejuvenation of anti-cancer response by immune checkpoint blockade using novel multifunctional nanoparticle to block CTLA-4 and eliminate ICER)

Loading